Global Pharmaceuticals & Biotech Big Green Snowflakes

Cian Healthcare

Market Cap: ₹95.2m

Engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India.

Theranexus Société Anonyme

Market Cap: €24.1m

A biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders.

Lophos Holdings

Market Cap: CA$858.6k

Through its subsidiaries, engages in the cultivation and research of peyote cactus.

Lowell Farms

Market Cap: CA$272.2k

Engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California.

Neutra

Market Cap: US$230.1k

Researches, develops, and provides hemp-derived products in the nutraceutical space in the United States.

Helix BioPharma

Market Cap: CA$113.0m

Operates as an immune-oncology company in Canada.

IntegraGen

Market Cap: €1.8m

Provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France.

Marvel Biosciences

Market Cap: CA$13.0m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

Reviva Pharmaceuticals Holdings

Market Cap: US$30.4m

A biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.

T2 Biosystems

Market Cap: US$364.6k

An in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally.

Mabwell (Shanghai) Bioscience

Market Cap: CN¥19.9b

A biopharmaceutical company, engages in the research and development, manufacture, and commercialization of biological products for oncology, immunology, bone disorders, ophthalmology, hematology, and infectious diseases in China and internationally.

Shanghai Fudan Forward S&T

Market Cap: CN¥4.7b

Operates in software development, biomedicine, real estate, and other businesses.

Hangzhou TianMuShan Pharmaceutical EnterpriseLtd

Market Cap: CN¥2.2b

Engages in the pharmaceutical manufacturing and drug distribution businesses in China.

International Stem Cell

Market Cap: US$1.1m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

Seoul Pharma

Market Cap: ₩37.4b

Manufactures and sells pharmaceutical products in South Korea and internationally.

FutureChemLtd

Market Cap: ₩464.0b

Engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally.

Pharmigene

Market Cap: NT$598.0m

Designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally.

BioPorto

Market Cap: DKK 604.7m

An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.

Shanghai Medicilon

Market Cap: CN¥10.1b

A contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally.

Sunny Pharmtech

Market Cap: NT$2.7b

Engages in the research, development, and sale of new and generic drug in Taiwan, the United States, and internationally.

Aton

Market Cap: €6.4m

Operates as a bioscience company in France.

Nanobiotix

Market Cap: €379.9m

Operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

New Leaf Ventures

Market Cap: CA$1.5m

Engages in processing, packaging, marketing, and distributing cannabis and related products.

Entasis Therapeutics Holdings

Market Cap: US$104.8m

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States.

Arbutus Biopharma

Market Cap: US$830.1m

A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.

ProtoKinetix

Market Cap: US$2.1m

A research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).

Avicanna

Market Cap: CA$32.4m

A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally.

InnoCan Pharma

Market Cap: CA$75.8m

A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.

Maravai LifeSciences Holdings

Market Cap: US$654.9m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Eupraxia Pharmaceuticals

Market Cap: CA$263.6m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Regencell Bioscience Holdings

Market Cap: US$6.7b

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

Allergy Therapeutics

Market Cap: UK£386.1m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

GB Sciences

Market Cap: US$81.4k

A plant-based research and biopharmaceutical drug development company.

PaxMedica

Market Cap: US$25.2k

A clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms.

ChoA Pharmaceutical

Market Cap: ₩38.2b

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea.

Dx & Vx

Market Cap: ₩120.8b

Engages in the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea.